ZF
Zachary B. Fleming
Chief Executive Officer

Zachary B. Fleming insider trades: Sanara MedTech (SMTI) stock sales

Chief Executive Officer, Sanara MedTech Last trade Nov 8, 2022 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2021
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Zachary reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 8, 2022SMTI↓ Sell$14K
Nov 4, 2022SMTI↓ Sell$19K
Nov 2, 2022SMTI↓ Sell$660
Jul 6, 2022SMTI↓ Sell$38K
Jun 29, 2022SMTI↓ Sell$8K
Jun 24, 2022SMTI↓ Sell$10K
Oct 26, 2021SMTI↓ Sell$34K
Oct 5, 2021SMTI↓ Sell$33K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Zachary B. Fleming's insider trades

Zachary B. Fleming is Chief Executive Officer at Sanara MedTech (SMTI). Since Oct 5, 2021, Zachary has reported no open-market purchases and 8 sales worth $155K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), shares withheld for taxes (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.